Literature DB >> 15702922

Homology model of the CDK1/cyclin B complex.

Connor F McGrath1, Nagarajan Pattabiraman, Glen E Kellogg, Thomas Lemcke, Conrad Kunick, Edward A Sausville, Daniel W Zaharevitz, Rick Gussio.   

Abstract

We describe a refined homology model of a CDK1/cyclin B complex that was previously used for the structure-based optimization of the Paullone class of inhibitors. The preliminary model was formed from the homologous regions of the deposited CDK2/cyclin A crystal structure. Further refinement of the CDK1/cyclin B complex was accomplished using molecular mechanics and hydropathic analysis with a protocol of constraints and local geometry searches. For the most part, our CKD1/cyclin B homology model is very similar to the high resolution CDK2/cyclin A crystal structure regarding secondary and tertiary features. However, minor discrepancies between the two kinase structures suggest the possibility that ligand design may be specifically tuned for either CDK1 or CDK2. Our examination of the CDK1/cyclin B model includes a comparison with the CDK2/cyclin A crystal structure in the PSTAIRE interface region, connecting portions to the ATP binding domain, as well as the ATP binding site itself.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15702922     DOI: 10.1080/07391102.2005.10531227

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  8 in total

Review 1.  Selectivity and potency of cyclin-dependent kinase inhibitors.

Authors:  Jayalakshmi Sridhar; Nagaraju Akula; Nagarajan Pattabiraman
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

2.  Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK-cyclin complexes and enhancement of p53 and cyclin H interaction.

Authors:  Hung-Chuan Chiu; Wei-Ru Huang; Tsai-Ling Liao; Pei-I Chi; Brent L Nielsen; Jyung-Hurng Liu; Hung-Jen Liu
Journal:  J Biol Chem       Date:  2018-06-15       Impact factor: 5.157

3.  Inhibition of cyclin-dependent kinase CDK1 by oxindolimine ligands and corresponding copper and zinc complexes.

Authors:  Rodrigo Bernardi Miguel; Philippe Alexandre Divina Petersen; Fernando A Gonzales-Zubiate; Carla Columbano Oliveira; Naresh Kumar; Rafael Rodrigues do Nascimento; Helena Maria Petrilli; Ana Maria da Costa Ferreira
Journal:  J Biol Inorg Chem       Date:  2015-09-28       Impact factor: 3.358

4.  CTLA-4 Facilitates DNA Damage-Induced Apoptosis by Interacting With PP2A.

Authors:  Qiongyu Yan; Bin Zhang; Xi Ling; Bin Zhu; Shenghui Mei; Hua Yang; Dongjie Zhang; Jiping Huo; Zhigang Zhao
Journal:  Front Cell Dev Biol       Date:  2022-02-24

5.  Biological activity, quantitative structure-activity relationship analysis, and molecular docking of xanthone derivatives as anticancer drugs.

Authors:  Isnatin Miladiyah; Jumina Jumina; Sofia Mubarika Haryana; Mustofa Mustofa
Journal:  Drug Des Devel Ther       Date:  2018-01-15       Impact factor: 4.162

6.  A Benzothiazole Derivative (5g) Induces DNA Damage And Potent G2/M Arrest In Cancer Cells.

Authors:  Mahesh Hegde; Supriya V Vartak; Chandagirikoppal V Kavitha; Hanumappa Ananda; Doddakunche S Prasanna; Vidya Gopalakrishnan; Bibha Choudhary; Kanchugarakoppal S Rangappa; Sathees C Raghavan
Journal:  Sci Rep       Date:  2017-05-31       Impact factor: 4.379

Review 7.  Bright Spots in The Darkness of Cancer: A Review of Starfishes-Derived Compounds and Their Anti-Tumor Action.

Authors:  Valentina Lazzara; Vincenzo Arizza; Claudio Luparello; Manuela Mauro; Mirella Vazzana
Journal:  Mar Drugs       Date:  2019-10-29       Impact factor: 5.118

8.  Identification of CDC25C as a Potential Biomarker in Hepatocellular Carcinoma Using Bioinformatics Analysis.

Authors:  Ruifeng Xun; Hougen Lu; Xianwang Wang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.